ALLO Allogene Therapeutics, Inc.
Healthcare$2.12+0.00%OpenMarket Cap: $516.0M
As of 2026-05-26
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 CNCR | Loncar Cancer Immunotherapy ETF | 60,621 | 3.29% |
 MOON | Direxion Moonshot Innovators ETF | 153,311 | 2.37% |
 BBC | Virtus Biotech Clinical Trials ETF | 180,588 | 1.22% |
 WDNA | 11,574 | 1.18% | |
 WBIO LN | 50,951 | 0.87% | |
 WDNA LN | 49,282 | 0.79% | |
 QQQS | Invesco NASDAQ Future Gen 200 ETF | 25,504 | 0.45% |
 BTAL | AGF U.S. Market Neutral Anti-Beta Fund | 16,936 | 0.42% |
 CANC | Tema Oncology ETF | 217,644 | 0.31% |
 MEDX | Horizon Kinetics Medical ETF | 17,582 | 0.23% |
 XBI | 5,212,606 | 0.17% | |
 LABU | Direxion Daily S&P Biotech Bull 3X ETF | 265,653 | 0.13% |
 PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 553,874 | 0.05% |
 IBBQ | Invesco Nasdaq Biotechnology ETF | 13,216 | 0.04% |
 BIB | ProShares - Ultra Nasdaq Biotechnology | 10,053 | 0.03% |
 IBB | iShares Biotechnology ETF | 1,145,572 | 0.03% |
 VTWV | 111,827 | 0.03% | |
 VHCAX | 5,189,570 | 0.03% | |
 VHCOX | 5,189,570 | 0.03% | |
 NAJ | 1,358,691 | 0.02% |